ADA Scientific Sessions 2025 Abstract

Diabetes Remission in Drug-Naïve Patients with Type 2 Diabetes (T2D) after Efsubaglutide Alfa Treatment

By Rui Sun, Yinxing Sun, Yulong Xu, Qinghua Wang, Jianhua Ma

Trial in peopleInterventions

The paper

Rui Sun, Yinxing Sun, Yulong Xu, Qinghua Wang, Jianhua Ma

Nanjing

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 740-P

doi.org/10.2337/db25-740-p

The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk